The Medicaid and CHIP Payment and Access Commission approved recommendations it will issue to Congress in its June report on oversight and increased transparency of artificial intelligence usage for prior authorization.
The Centers for Disease Control and Prevention released a Health Alert Network Health Advisory May 8 notifying clinicians and health departments of the potential for imported cases of hantavirus disease, but said the risk of broad spread to the U.S. is currently extremely unlikely.
In honor of National Hospital Week, the AHA is again teaming up with Musicians On Call to send messages of support from singers and songwriters to hospital and health system workers and leaders around the country.
Elinore Kaufman, M.D., medical director of the Penn Trauma Violence Recovery Program, and Michele Volpe, chief operating officer of the University of Pennsylvania Health System, share how hospital-based violence intervention programs are helping patients heal physically, emotionally and socially after traumatic injury.
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software-related battery issue that could cause affected devices to enter Safety Mode and limit pacing functionality
The measles outbreak in Utah that began in June 2025 has grown to 638 cases as of May 5, according to the state’s Department of Health and Human Services.
Microsoft Threat Intelligence is warning of a large scale, multistage phishing campaign that disproportionately targeted the health care sector, sending “code of conduct” themed emails to lure users into credential theft and token compromise.
National Hospital Week is an opportunity to highlight our hospitals, health systems and health care workers and the innovative ways they are supporting and connected to their community.
The Department of Health and Human Services published an interim final rule May 7 to delay compliance dates for entities receiving federal financial assistance to comply with certain requirements under Section 504 of the Rehabilitation Act.
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible Medicare Part D beneficiaries for $50 per month beginning July 1 this year through Dec. 31, 2027.
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to supplier issues, and expects the issue to continue through the end of the year.
The Centers for Medicare & Medicaid Services May 5 announced a new electronic prior authorization initiative as part of its Health Technology Ecosystem.